late 1
relapses 1
following 1
highdose 1
autologous 1
stem 1
cell 2
transplantation 1
hdasct 1
hodgkins 2
lymphoma 5
hl 1
abvd 1
therapeutic 1
era 1
combination 1
bendamustine 1
bortezomib 2
rituximab 2
patients 2
relapsedrefractory 1
indolent 2
mantle 1
nonhodgkin 1
phase 1
ii 1
study 1
tlr 1
agonist 1
iss 1
relapsed 2
refractory 2
follicular 1
gemcitabine 1
profound 1
hypogammaglobulinemia 1
years 1
treatment 1
